NDC 69238-2675-01 - Amlodipine and Olmesartan Medoxomil
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 69238-2675
- Requested NDC
- 69238-2675-01
- Package NDCs from labels
- 69238-2675-1, 69238-2675-01
- Manufacturer
- AvKARE
- Effective date
- 2026-01-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Amlodipine and Olmesartan Medoxomil - AvKARE | AvKARE | 2026-01-13 | HUMAN PRESCRIPTION DRUG LABEL |
| AMLODIPINE - Amneal Pharmaceuticals NY LLC | ScieGen Pharmaceuticals, Inc | Amneal Pharmaceuticals NY LLC | ScieGen Pharmaceuticals, Inc | 2024-03-26 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69238-2675-1 | Amlodipine and Olmesartan Medoxomil | 1000 in 1 BOTTLE | TABLET, FILM COATED | 1000 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 69238-2675 | AMLODIPINE AND OLMESARTAN MEDOXOMIL TABLET, FILM COATED [AMNEAL PHARMACEUTICALS NY LLC] | 1 | Current NDC, 1 package rows | 20240502_02f9b562-6f7f-4783-bb0d-67c318073e1c.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Silicea | SILICON DIOXIDE | Boiron | 86d395ec-3c3b-5e5f-e053-2a91aa0a3f9c | 2023-02-20 | ETJ7Z6XBU4 | |
| EyeClear Pro | CALC CARB, CALC FLUOR, CAUSTICUM, CINERARIA, EUPHRASIA, NAPHTHALINUM, NAT MUR, PHOS, QUASSIA, SILICEA | Silver Star Brands | f4d4943b-cb78-aa71-e053-2a95a90ac638 | 2023-02-16 | Warnings | ETJ7Z6XBU4 |
| Norvasc | AMLODIPINE BESYLATE | Viatris Specialty LLC | 7367289c-b0b0-466a-83e2-558e2985c29f | 2023-02-15 | Warnings, Adverse reactions | 864V2Q084H |
| CellTropin | ARGININE, GINKGO BILOBA, HYPOPHYSIS SUIS, SILICEA, ASTRAGALUS EXCAPUS | Micro Balance Health Products LLC | 502d3ffa-bbf4-403a-9fad-b6b229f36a8c | 2023-02-14 | Warnings | ETJ7Z6XBU4 |
| Mineral Sunscreen SPF 50 | ZINC OXIDE TITANIUM DIOXIDE | Topiderm, Inc. | 3a637542-0f79-47ae-815d-84d0036c737a | 2023-02-13 | Warnings | 15FIX9V2JP |
| laxative | POLYETHYLENE GLYCOL 3350 | Rite Aid Corporation | 3ebe9191-8e0a-41cf-b759-82ecce4f50e4 | 2023-02-10 | Warnings | G2M7P15E5P |
| POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES | POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES | Novel Laboratories, Inc. | 29d821ff-389c-41fb-8a27-89bd3f022b82 | 2023-02-08 | Warnings, Adverse reactions | G2M7P15E5P |
| dg health clearlax | POLYETHYLENE GLYCOL 3350 | Dolgencorp, LLC | 94280ce4-b2cf-451d-a660-b26ab1a2d3f0 | 2023-02-06 | Warnings | G2M7P15E5P |
| Amlodipine and Valsartan | AMLODIPINE AND VALSARTAN | Alembic Pharmaceuticals Limited | a9c442dc-749e-4de0-bca3-1044eb78da72 | 2023-01-27 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| clearlax | POLYETHYLENE GLYCOL 3350 | H E B | 0b4b752d-045d-4ff0-8e50-5607d1a841a7 | 2023-01-26 | Warnings | G2M7P15E5P |
| Good Sense Clear Lax | POLYETHYLENE GLYCOL 3350 | L. Perrigo Company | 435db89c-1e32-4da5-b7d0-15e407162715 | 2023-01-24 | Warnings | G2M7P15E5P |
| Amlodipine besylate and Olmesartran medoxomil | AMLODIPINE BESYLATE AND OLMESARTRAN MEDOXOMIL | Alembic Pharmaceuticals Limited | cb2df7f7-fee8-42ba-8936-0788c4fcc0cb | 2023-01-23 | Boxed warning, Warnings, Adverse reactions | 730872 730866 730861 730869 864V2Q084H 6M97XTV3HD |
| Silicea | SILICON DIOXIDE | Boiron | 86d2db09-9c46-37f7-e053-2a91aa0a326f | 2023-01-23 | ETJ7Z6XBU4 | |
| Silicea | SILICON DIOXIDE | Boiron | 86d3be33-b50e-e649-e053-2a91aa0acfc5 | 2023-01-23 | ETJ7Z6XBU4 | |
| Silicea | SILICON DIOXIDE | Boiron | 86d3be33-b4fb-e649-e053-2a91aa0acfc5 | 2023-01-23 | ETJ7Z6XBU4 | |
| Olmesartan Medoxomil and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Limited | 8c65d555-8db8-40d9-be30-309ef09f19be | 2023-01-19 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | Alembic Pharmaceuticals Limited | ac08ea7d-f529-42ca-850a-a0ecce7dc830 | 2023-01-18 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| Josie Maran Argan Daily Moisturizer SPF47 | ZINC OXIDE, TITANIUM DIOXIDE | Autumn Harp, Inc. | 027821e6-db7d-4c03-956a-00313488ebc7 | 2023-01-14 | Boxed warning, Warnings | 15FIX9V2JP |
| Gyno Complex | VIBURNUM OPULUS, MAGNESIA PHOSPHORICA, FOLLICULINUM, PULSATILLA (PRATENSIS), BORAX, MERCURIUS SOLUBILIS, NITRICUM ACIDUM, SILICEA, THUJA OCCIDENTALIS | Deseret Biologicals, Inc | dfaaa56a-4226-4f62-a219-d3f89fe7afe3 | 2023-01-12 | Warnings | ETJ7Z6XBU4 |
| Silicea | SILICON DIOXIDE | Boiron | 86d367e5-e846-54ba-e053-2991aa0a63d4 | 2023-01-12 | ETJ7Z6XBU4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.